---
schema_version: "secwatch.filing_event.v1"
accession: "0001326110-25-000040"
form_type: "8-K"
ticker: "IBRX"
cik: "0001326110"
company_name: "ImmunityBio, Inc."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:35:41.484431+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ImmunityBio replaces auditor EY with Deloitte for fiscal year 2025

## Summary
- Audit committee dismissed Ernst & Young as independent auditor on March 13, 2025; no disagreements or reportable events.
- Deloitte & Touche appointed as new independent auditor for fiscal year ending Dec 31, 2025, subject to client acceptance.
- EY provided a letter (Exhibit 16.1) agreeing with the company's disclosures in this 8-K.
- Company did not consult Deloitte on accounting principles during the two most recent fiscal years.

## SEC filing metadata
- accession: 0001326110-25-000040
- form_type: 8-K
- ticker: IBRX
- cik: 0001326110
- company_name: ImmunityBio, Inc.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326110/000132611025000040/0001326110-25-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326110/000132611025000040/ibrx-20250313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001326110-25-000040
- JSON: https://secwatch.observer/filing/0001326110-25-000040.json
- Plain text: https://secwatch.observer/filing/0001326110-25-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.